Universidade Federal de Alfenas Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2018
NCT05558397
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Alfenas Federal University | SINPAIN LTDA | Sinpain Ltda; Universidade Federal de Alfenas | UNIFAL-MG | Universidade Federal de Alfenas

Active Ingredients

Drugs in Phase 4 Trials (2)

morphine (1 trial)

pregabalin (lyrica) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Agnosia (Phase 4)

Opioid-Related Disorders (Phase 4)

Pain, Postoperative (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2